FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2268988891> ?p ?o ?g. }

• W2268988891 endingPage "70" @default.
• W2268988891 startingPage "62" @default.
• W2268988891 abstract "To evaluate the safety and efficacy of gevokizumab for the treatment of Behçet's disease uveitis in a prospective, open-label, randomized phase 2 trial.Behçet's disease patients with new acute ocular exacerbation or at risk of exacerbation received 30 or 60 mg gevokizumab every 4 weeks intravenously or subcutaneously, on top of a stable regimen of immunosuppressives and corticosteroids (≤20 mg/day equivalent prednisolone). Patients withdrew in cases of ocular exacerbation.A total of 21 patients were included (17 acute and 4 at-risk; mean duration of uveitis 45.6 ± 37.4 months). There were no serious adverse events related to gevokizumab. Recorded adverse events were mostly associated with exacerbation of uveitis or its complications. Response was evaluated for 14 acute patients and all showed rapid control of acute ocular exacerbation, mostly within 1 week, without any increase in corticosteroid dosage.Gevokizumab was well tolerated and rapidly controlled acute ocular exacerbations of Behçet's disease uveitis without the need for high-dose corticosteroid." @default.
• W2268988891 created "2016-06-24" @default.
• W2268988891 creator A5003591041 @default.
• W2268988891 creator A5009694157 @default.
• W2268988891 creator A5024011459 @default.
• W2268988891 creator A5026394890 @default.
• W2268988891 creator A5036024286 @default.
• W2268988891 creator A5046315568 @default.
• W2268988891 creator A5050397979 @default.
• W2268988891 creator A5054104928 @default.
• W2268988891 creator A5066583973 @default.
• W2268988891 creator A5068487851 @default.
• W2268988891 creator A5072278622 @default.
• W2268988891 creator A5086742099 @default.
• W2268988891 date "2016-01-30" @default.
• W2268988891 modified "2023-10-14" @default.
• W2268988891 title "Safety and Efficacy of Gevokizumab in Patients with Behçet’s Disease Uveitis: Results of an Exploratory Phase 2 Study" @default.
• W2268988891 cites W1965435514 @default.
• W2268988891 cites W2053365177 @default.
• W2268988891 cites W2059161979 @default.
• W2268988891 cites W2060803497 @default.
• W2268988891 cites W2064729318 @default.
• W2268988891 cites W2072054779 @default.
• W2268988891 cites W2101832554 @default.
• W2268988891 cites W2118968774 @default.
• W2268988891 cites W2121745904 @default.
• W2268988891 cites W2139499737 @default.
• W2268988891 cites W2143190437 @default.
• W2268988891 cites W2147171610 @default.
• W2268988891 cites W4233230329 @default.
• W2268988891 cites W4235673640 @default.
• W2268988891 cites W4246894230 @default.
• W2268988891 cites W4256264175 @default.
• W2268988891 doi "https://doi.org/10.3109/09273948.2015.1092558" @default.
• W2268988891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26829647" @default.
• W2268988891 hasPublicationYear "2016" @default.
• W2268988891 type Work @default.
• W2268988891 sameAs 2268988891 @default.
• W2268988891 citedByCount "50" @default.
• W2268988891 countsByYear W22689888912016 @default.
• W2268988891 countsByYear W22689888912017 @default.
• W2268988891 countsByYear W22689888912018 @default.
• W2268988891 countsByYear W22689888912019 @default.
• W2268988891 countsByYear W22689888912020 @default.
• W2268988891 countsByYear W22689888912021 @default.
• W2268988891 countsByYear W22689888912022 @default.
• W2268988891 countsByYear W22689888912023 @default.
• W2268988891 crossrefType "journal-article" @default.
• W2268988891 hasAuthorship W2268988891A5003591041 @default.
• W2268988891 hasAuthorship W2268988891A5009694157 @default.
• W2268988891 hasAuthorship W2268988891A5024011459 @default.
• W2268988891 hasAuthorship W2268988891A5026394890 @default.
• W2268988891 hasAuthorship W2268988891A5036024286 @default.
• W2268988891 hasAuthorship W2268988891A5046315568 @default.
• W2268988891 hasAuthorship W2268988891A5050397979 @default.
• W2268988891 hasAuthorship W2268988891A5054104928 @default.
• W2268988891 hasAuthorship W2268988891A5066583973 @default.
• W2268988891 hasAuthorship W2268988891A5068487851 @default.
• W2268988891 hasAuthorship W2268988891A5072278622 @default.
• W2268988891 hasAuthorship W2268988891A5086742099 @default.
• W2268988891 hasBestOaLocation W22689888911 @default.
• W2268988891 hasConcept C118487528 @default.
• W2268988891 hasConcept C126322002 @default.
• W2268988891 hasConcept C141071460 @default.
• W2268988891 hasConcept C197934379 @default.
• W2268988891 hasConcept C2776194053 @default.
• W2268988891 hasConcept C2776715498 @default.
• W2268988891 hasConcept C2776804153 @default.
• W2268988891 hasConcept C2777014857 @default.
• W2268988891 hasConcept C2779134260 @default.
• W2268988891 hasConcept C2781413609 @default.
• W2268988891 hasConcept C2781428731 @default.
• W2268988891 hasConcept C71924100 @default.
• W2268988891 hasConceptScore W2268988891C118487528 @default.
• W2268988891 hasConceptScore W2268988891C126322002 @default.
• W2268988891 hasConceptScore W2268988891C141071460 @default.
• W2268988891 hasConceptScore W2268988891C197934379 @default.
• W2268988891 hasConceptScore W2268988891C2776194053 @default.
• W2268988891 hasConceptScore W2268988891C2776715498 @default.
• W2268988891 hasConceptScore W2268988891C2776804153 @default.
• W2268988891 hasConceptScore W2268988891C2777014857 @default.
• W2268988891 hasConceptScore W2268988891C2779134260 @default.
• W2268988891 hasConceptScore W2268988891C2781413609 @default.
• W2268988891 hasConceptScore W2268988891C2781428731 @default.
• W2268988891 hasConceptScore W2268988891C71924100 @default.
• W2268988891 hasFunder F4320327235 @default.
• W2268988891 hasIssue "1" @default.
• W2268988891 hasLocation W22689888911 @default.
• W2268988891 hasLocation W22689888912 @default.
• W2268988891 hasOpenAccess W2268988891 @default.
• W2268988891 hasPrimaryLocation W22689888911 @default.
• W2268988891 hasRelatedWork W1996414422 @default.
• W2268988891 hasRelatedWork W2050928843 @default.
• W2268988891 hasRelatedWork W2076605613 @default.
• W2268988891 hasRelatedWork W2076712150 @default.
• W2268988891 hasRelatedWork W2097208648 @default.
• W2268988891 hasRelatedWork W2121179933 @default.
• W2268988891 hasRelatedWork W2130452960 @default.

• next